Your browser doesn't support javascript.
loading
Efficacy and safety of dexmedetomidine as an intrathecal agent: a dose finding clinical study
Arvinder Pal, Singh; Sunil, Chawla; Sukhminder Jit Singh, Bajwa; Menaal, Khanna.
Anaesthesia, Pain and Intensive Care. 2017; 21 (1): 13-18
in English | IMEMR | ID: emr-187457
ABSTRACT
Background and

Objectives:

Dexmedetomidine is increasingly being used in regional anesthesia as an adjuvant but there is no consensus on exact minimal and safe dose when used intrathecally. The present study was conducted to evaluate the efficacy of three different doses of dexmedetomidine when given intrathecally as an adjuvant to bupivacaine in patients undergoing lower abdominal surgery
Subject(s)
Search on Google
Print
XML
Index: IMEMR (Eastern Mediterranean) Main subject: Injections, Spinal / Bupivacaine / Double-Blind Method / Treatment Outcome / Abdominal Cavity / Drug Therapy, Combination / Biomarkers, Pharmacological Type of study: Controlled clinical trial Limits: Adult / Female / Humans / Male Language: English Journal: Anaesth. Pain Intensive Care Year: 2017

Similar

MEDLINE
LILACS
LIS
Search on Google
Print
XML
Index: IMEMR (Eastern Mediterranean) Main subject: Injections, Spinal / Bupivacaine / Double-Blind Method / Treatment Outcome / Abdominal Cavity / Drug Therapy, Combination / Biomarkers, Pharmacological Type of study: Controlled clinical trial Limits: Adult / Female / Humans / Male Language: English Journal: Anaesth. Pain Intensive Care Year: 2017